Human Growth Hormone Market Growth Opportunities: Insights from 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Anticipated Size Of The Human Growth Hormone Market Over The Five-Year Period 2025–2029?

The human growth hormone market size has demonstrated strong expansion in recent years. This market is anticipated to increase from $4.75 billion in 2024 to $5.18 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.0%. The historical growth of this market can be attributed to the rising prevalence of growth disorders, increased awareness regarding hormone therapies, the expanding applications within sports medicine, an aging global population, and improvements in healthcare infrastructure.

The human growth hormone market is anticipated to show significant expansion over the next few years. It is predicted to reach a size of $7.32 billion by 2029, advancing at a compound annual growth rate (CAGR) of 9.0%. This growth during the forecast period is attributable to the emergence of personalized medicine, an increase in global healthcare expenditure, the growing adoption of recombinant DNA technology, a rising demand for hormone replacement therapies, and the increasing prevalence of endocrine disorders. Notable trends expected in the forecast period include the expansion of distribution networks in developing markets, the integration of artificial intelligence in drug development, an emphasis on sustainable manufacturing processes, the creation of long-acting formulations, and the utilization of combination therapies for enhanced efficacy.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15825&type=smp

Which Major Market Drivers Are Shaping The Future Of The Human Growth Hormone Market?

Increased understanding of treatment options is anticipated to drive the expansion of the human growth hormone market in the future. Medical interventions aimed at relieving, controlling, or resolving health conditions or illnesses are defined as treatment procedures. This heightened awareness regarding treatment procedures stems from progress in medical technology, wider availability of information via digital platforms, and a surging public focus on health and well-being. Human growth hormone (HGH) therapies have attracted considerable media coverage and public fascination, underscoring the advantages and possible uses of contemporary medical interventions, which, in turn, boosts general knowledge of treatment procedures. An illustrative example is found in November 2023 data from The 2022 National Survey on Drug Use and Health (NSDUH), a publication by the Substance Abuse and Mental Health Services Administration (SAMHSA), a US-based Department of Health and Human Services. This report indicates that among adolescents aged 12 to 17, in 2021, 40.6% of the 5.0 million adolescents experiencing a past year Major Depressive Episode (MDE) received treatment for depression. This figure rose in 2022, with 56.8% of the 4.8 million adolescents with a past year MDE receiving mental health treatment. Consequently, the increased recognition of treatment procedures is propelling the expansion of the human growth hormone market.

What Are The Segment Types Shaping The Human Growth Hormone Market?

The human growth hormonemarket covered in this report is segmented –

1) By Product: Liquid; Powder

2) By Brand: Norditropin; Genotropin; Humatrope; Saizen; Omnitrope; Skytrofa; Others Brands

3) By Route Of Administration: Oral; Intravenous; Intramuscular; Subcutaneous

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacy; Specialty Pharmacy

5) By Application: Growth Hormone (GH) Deficiency; Adult Growth Hormone (GH) Deficiency; Pediatric Growth Hormone (GH) Deficiency; Turner Syndrome; Idiopathic Short Stature; Prader-Willi Syndrome; Small For Gestational Age; Other Applications

Subsegments:

1) By Liquid: Pre-Filled Liquid Syringes; Vials Of Liquid Growth Hormone

2) By Powder: Reconstitutable Powder; Freeze-Dried Powder

What Key Innovation Trends Are Fueling Advancements In The Human Growth Hormone Market?

Leading companies in the human growth hormone market are intensifying their efforts in drug development and its subsequent approvals to advance their medication offerings and deliver improved treatment solutions. Developing new drugs is a complex and stringent process, involving multiple stages to ensure a drug’s safety, efficacy, and quality before it becomes available to the public. For example, in June 2023, Pfizer Inc., a US-based biopharmaceutical company, and OPKO Health Inc., a US-based biopharmaceutical and diagnostics company, announced that the Food and Drug Administration (FDA) had approved NGENLA (somatrogon-ghla). This therapy presents a more convenient dosing schedule and boosts patient adherence compared to daily injections. It offers children with growth hormone deficiency the choice to reduce injection frequency from daily to just once a week. The FDA’s approval was backed by a Phase 3 study, which confirmed NGENLA’s non-inferiority when compared to once-daily somatropin, along with a safety profile comparable to somatropin.

Who Are The Top Performing Companies In The Human Growth Hormone Market In Recent Years?

Major companies operating in the human growth hormone market are Pfizer Inc., Roche Holding AG, Novartis AG, Thermo Fisher Scientific Inc., Eli Lilly and Company, Novo Nordisk A/S, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Ipsen Pharma, Ferring Holding SA, Endo International, Zydus Lifesciences Limited, Opko Health, LG Life Sciences, EMD Serono Inc., Wockhardt Ltd., JCR Pharmaceuticals Co. Ltd., Genentech Inc., Shanghai United Imaging Healthcare Co. Ltd., SOFAR S.p.A., United Laboratories, Ascendis Pharma, Uni-Pharma S.A., Versartis Inc., Reliance Life Sciences, Anhui Anke Biotechnology (Group) Co. Ltd., Rani Therapeutics

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/human-growth-hormone-global-market-report

Which Region Is Projected To Lead The Human Growth Hormone Market During The Forecast Period?

North America was the largest region in the human growth hormone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human growth hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Human Growth Hormone Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15825&type=smp

Browse Through More Reports Similar to the Global Human Growth Hormone Market 2025, By The Business Research Company

Biosimilar Growth Hormone Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report

Parathyroid Hormones Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report

Biosimilar Hormone Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795